Komen Foundation grant enables TGen scientists to study triple-negative breast cancer

[News]

The Translational Genomics Research Institute (TGen) is part of a team of medical investigators receiving a $3.5 million grant from Susan G. Komen for the Cure to study triple-negative breast cancer, a highly aggressive form of this cancer that disproportionately affects African-Americans.

More... (http://www.news-medical.net/news/20110926/Komen-Foundation-grant-enables-TGen-scientists-to-study-triple-negative-breast-cancer.aspx)